Company Profiles

driven by the PitchBook Platform

Encycle Therapeutics

Encycle Therapeutics
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.15M LATEST DEAL AMOUNT
$5.49M TOTAL AMOUNT RAISED
Description

Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's drugs are generated by several scaffolds that are membrane permeable and orally bioavailable products, such as nacellins which are ideal for targeting protein-protein interactions, enabling patients to get cured from inflammatory bowel disease and other inflammatory disorders.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
101 College Street
Suite 314
Toronto, Ontario M5G 1L7
Canada

+1 (647) 258-4500
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Encycle Therapeutics’s full profile, request a free trial.

Encycle Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 30-Sep-2015 $2.15M $5.49M Completed Startup
3. Early Stage VC 16-Jun-2015 00000 00.000 Completed Startup
2. Grant 17-Nov-2014 $2.5M Completed Startup
1. Early Stage VC 11-Nov-2014 $2.5M $2.5M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Encycle Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
Business Development Bank of Canada Venture Capital Minority 000 0000 000000 0
CQDM Other Minority 000 0000 000000 0
MaRS Innovation Not-For-Profit Venture Capital Minority 000 0000 000000 0
MaRS Investment Accelerator Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Encycle Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Jeffrey Coull Ph.D President, Board Member & Chief Executive Officer
Andrei Yudin Ph.D Board Member & Scientific Founder, SAB
Andrew Roughton Ph.D Vice President, Discovery and Operations & Board Observer

Encycle Therapeutics Board Members (11)

Name Representing Role Since Contact
Info
Andrei Yudin Ph.D Encycle Therapeutics Board Member & Scientific Founder, SAB 000 0000
Andrew Roughton Ph.D Encycle Therapeutics Vice President, Discovery and Operations & Board Observer 000 0000
Frederic Lemaitre Auger Ph.D Self Board Member 000 0000
Jennifer Fraser Encycle Therapeutics Board Member 000 0000
Kevin Koch Ph.D Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »